Moreover, TRIM32 was a significant predictor of the prognosis of hepatocellular carcinoma (HCC), and the overexpression of TRIM32 may induce HCC patients’ resistance to oxaliplatin (11). Here, TRIM32 is linked to hepatocellular carcinoma.